Literature DB >> 19661501

Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively.

Alexandr Nemec1, Martin Musílek, Ondrej Sedo, Thierry De Baere, Martina Maixnerová, Tanny J K van der Reijden, Zbynek Zdráhal, Mario Vaneechoutte, Lenie Dijkshoorn.   

Abstract

Acinetobacter genospecies (genomic species) 10 and 11 were described by Bouvet and Grimont in 1986 on the basis of DNA-DNA reassociation studies and comprehensive phenotypic analysis. In the present study, the names Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., respectively, are proposed for these genomic species based on the congruence of results of polyphasic analysis of 33 strains (16 and 17 strains of genomic species 10 and 11, respectively). All strains were investigated by selective restriction fragment amplification (i.e. AFLP) analysis rpoB sequence analysis, amplified rDNA restriction analysis and tDNA intergenic length polymorphism analysis, and their nutritional and physiological properties were determined. Subsets of the strains were studied by 16S rRNA gene sequence analysis and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS or had been classified previously by DNA-DNA reassociation. Results indicate that A. bereziniae and A. guillouiae represent two phenetically and phylogenetically distinct groups within the genus Acinetobacter. Based on the comparative analysis of housekeeping genes (16S rRNA and rpoB genes), these species together represent a monophyletic branch within the genus. Despite their overall phenotypic similarity, the ability to oxidize d-glucose and to grow at 38 degrees C can be used in the presumptive differentiation of these two species from each other: with the exception of three strains that were positive for only one test, A. bereziniae strains were positive for both tests, whereas A. guillouiae strains were negative in these tests. The strains of A. bereziniae originated mainly from human clinical specimens, whereas A. guillouiae strains were isolated from different environmental sources in addition to human specimens. The type strain of A. bereziniae sp. nov. is LMG 1003(T) (=CIP 70.12(T) =ATCC 17924(T)) and that of A. guillouiae sp. nov. is LMG 988(T) (=CIP 63.46( T) =ATCC 11171(T) =CCUG 2491(T)).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661501     DOI: 10.1099/ijs.0.013656-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  20 in total

1.  Identical miniature inverted repeat transposable elements flank class 1 integrons in clinical isolates of Acinetobacter spp.

Authors:  Sara Domingues; Mark A Toleman; Kaare M Nielsen; Gabriela J da Silva
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

2.  Genetic diversity of endophytic diazotrophs of the wild rice, Oryza alta and identification of the new diazotroph, Acinetobacter oryzae sp. nov.

Authors:  Hassan Javed Chaudhary; Guixiang Peng; Mei Hu; Yumei He; Lijuan Yang; Yan Luo; Zhiyuan Tan
Journal:  Microb Ecol       Date:  2011-11-22       Impact factor: 4.552

3.  Acinetobacter oleivorans sp. nov. is capable of adhering to and growing on diesel-oil.

Authors:  Yoon-Suk Kang; Jaejoon Jung; Che Ok Jeon; Woojun Park
Journal:  J Microbiol       Date:  2011-03-03       Impact factor: 3.422

4.  Biochemical and genetic characterization of carbapenem-hydrolyzing β-lactamase OXA-229 from Acinetobacter bereziniae.

Authors:  Rémy A Bonnin; Alain A Ocampo-Sosa; Laurent Poirel; Hélène Guet-Revillet; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

5.  Acinetobacter kyonggiensis sp. nov., a β-glucosidase-producing bacterium, isolated from sewage treatment plant.

Authors:  Hye-Jung Lee; Sang-Seob Lee
Journal:  J Microbiol       Date:  2011-01-09       Impact factor: 3.422

6.  Biochemical and molecular mechanisms involved in simultaneous phenol and Cr(VI) removal by Acinetobacter guillouiae SFC 500-1A.

Authors:  Ornella M Ontañon; Paola S González; Elizabeth Agostini
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-29       Impact factor: 4.223

7.  Bacteremia due to Acinetobacter genomic species 10.

Authors:  Shu-Chen Kuo; Chang-Phone Fung; Yi-Tzu Lee; Chien-Pei Chen; Te-Li Chen
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

8.  Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?

Authors:  Anna de Breij; Lenie Dijkshoorn; Ellen Lagendijk; Joke van der Meer; Abraham Koster; Guido Bloemberg; Ron Wolterbeek; Peterhans van den Broek; Peter Nibbering
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  Identification of NDM-1 in a Putatively Novel Acinetobacter Species ("NB14") Closely Related to Acinetobacter pittii.

Authors:  Paula Espinal; Noraida Mosqueda; Murat Telli; Tanny van der Reijden; Dora Rolo; Dietmar Fernández-Orth; Lenie Dijkshoorn; Ignasi Roca; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

10.  Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp.

Authors:  Bruno Périchon; Sylvie Goussard; Violaine Walewski; Lenka Krizova; Gustavo Cerqueira; Cheryl Murphy; Michael Feldgarden; Jennifer Wortman; Dominique Clermont; Alexandr Nemec; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.